BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6129465)

  • 1. Penicillamine nephropathy and iron.
    Harkness JA; Blake DR
    Lancet; 1982 Dec; 2(8312):1368-9. PubMed ID: 6129465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine and iron.
    Lyle WH
    Lancet; 1976 Aug; 2(7982):420. PubMed ID: 73880
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.
    Williams AJ; Fordham JN; Barnes CG; Goodwin FJ
    Ann Rheum Dis; 1986 Jan; 45(1):82-4. PubMed ID: 3954462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: D-penicillamine-induced membranous glomerulonephritis.
    Neild GH; Gärtner HV; Bohle A
    Lancet; 1975 May; 1(7917):1201-2. PubMed ID: 48830
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 8. D-penicillamine therapy associated with rapidly progressive glomerulonephritis.
    Macarrón P; García Díaz JE; Azofra JA; Martín de Francisco J; Gonzalez E; Fernandez G; Sampedro J
    Nephrol Dial Transplant; 1992; 7(2):161-4. PubMed ID: 1314978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1984 Oct; 11(5):584-5. PubMed ID: 6392549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent naproxen- and penicillamine-induced renal disease in rheumatoid arthritis.
    Quigley MR; Richfield M; Krumlovsky FA; Kanwar YS; Carone FA; Jarrett MP
    Arthritis Rheum; 1982 Aug; 25(8):1016-9. PubMed ID: 7115444
    [No Abstract]   [Full Text] [Related]  

  • 12. [D-penicillamine and glomerulonephritis].
    Altrogge G; Hofmann K; Huth F; Grabensee B; Schoppe WD
    Med Welt; 1976 Nov; 27(47):2282-3. PubMed ID: 1004174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extramembranous glomerulonephritis induced by D-penicillamine. Description of a case].
    Miguel Donderis A; Sánchez Vegazo I; Gómez Campdera FJ; Gallego JL; Fernández Fernández J; Sanz Guajardo D; Botella J
    Rev Clin Esp; 1981 Jan; 160(2):137-8. PubMed ID: 7209061
    [No Abstract]   [Full Text] [Related]  

  • 14. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 15. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis.
    Banfi G; Imbasciati E; Guerra L; Mihatsch MJ; Ponticelli C
    Nephron; 1983; 33(1):56-60. PubMed ID: 6339966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course of penicillamine nephropathy: a long term study of 33 patients.
    Hall CL; Jawad S; Harrison PR; MacKenzie JC; Bacon PA; Klouda PT; MacIver AG
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1083-6. PubMed ID: 3132218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffuse alveolar hemorrhage and severe glomerulonephritis induced by D-penicillamine. Apropos of a case report with review of the literature].
    Bonan G; Caubarrere I; Beaufils H; Lucsko M; Aubert P
    Therapie; 1986; 41(4):297-8. PubMed ID: 3576513
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillamine in rheumatoid arthritis. A problem of toxicity.
    Taylor HG; Samanta A
    Drug Saf; 1992; 7(1):46-53. PubMed ID: 1536698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.